Retinal implants show promise in macular degeneration

Comment

. 2018 Jun;14(6):317.

doi: 10.1038/s41582-018-0007-x.

Affiliations

Comment

Heather Wood. Nat Rev Neurol. 2018 Jun.

. 2018 Jun;14(6):317.

doi: 10.1038/s41582-018-0007-x.

No abstract available

Comment on

Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.
da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM, Gooljar SB, Carr AF, Vugler A, Ramsden CM, Bictash M, Fenster M, Steer J, Harbinson T, Wilbrey A, Tufail A, Feng G, Whitlock M, Robson AG, Holder GE, Sagoo MS, Loudon PT, Whiting P, Coffey PJ. da Cruz L, et al. Nat Biotechnol. 2018 Apr;36(4):328-337. doi: 10.1038/nbt.4114. Epub 2018 Mar 19. Nat Biotechnol. 2018. PMID: 29553577 Clinical Trial.
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin CM, Mitra D, Zhu D, Thomas BB, Hikita ST, Pennington BO, Johnson LV, Clegg DO, Hinton DR, Humayun MS. Kashani AH, et al. Sci Transl Med. 2018 Apr 4;10(435):eaao4097. doi: 10.1126/scitranslmed.aao4097. Sci Transl Med. 2018. PMID: 29618560 Clinical Trial.